Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Vita Leonardi"'
Autor:
Giuseppe Carruba, Maria Luisa Calagna, Ildegarda Campisi, Stella Cutrera, Laura Napoli, Giovanni Pitti, Valentina Palmisano, Giuseppina Savio, Antonella Usset, Vita Leonardi, Angela Di Pasquale, Salvatore Requirez, Livio Blasi
Publikováno v:
Diseases, Vol 10, Iss 3, p 47 (2022)
This paper presents a multi-professional integrated approach toward the recognition and management of the nutritional and psychological needs of cancer patients. In particular, the patients undertook a multi-professional, multistep process that inclu
Externí odkaz:
https://doaj.org/article/03d5db1e69764c89878932cc83e6c2c9
Autor:
Laura Pizzuti, Laura Cortesi, Barbara Tagliaferri, Armando Santoro, Patrizia Vici, A. Gambaro, Rita De Sanctis, Raffaella Palumbo, Alessandra Fabi, Vita Leonardi, Rosalba Torrisi, Maria Rosaria Valerio, Rossana Gueli, Marina Elena Cazzaniga, Giulia Bianchi
Publikováno v:
Breast Cancer Research and Treatment. 190:103-109
Purpose: The most appropriate therapy for HR + /HER2-positive (HER2 +) advanced breast cancer (ABC) is a matter of debate. Co-targeting of both receptors represents an attractive strategy to overcome the cross-talk between them. Methods: The HERMIONE
Autor:
Stefania Gori, Alessandro Inno, Valentina Rossi, Monica Turazza, Elena Fiorio, Alessandra Fabi, Giancarlo Bisagni, Jennifer Foglietta, Daniele Santini, Ida Pavese, Arianna Pellegrino, Alberto Zambelli, Patrizia Vici, Vita Leonardi, Sandro Barni, Silvana Saracchini, Giuseppe Bogina, Fabiana Marchetti, Simona Duranti, Gianluigi Lunardi, Filippo Montemurro
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0156221 (2016)
BACKGROUND:There are no validated predictive markers for lapatinib and capecitabine in patients with trastuzumab-resistant HER2 positive metastatic breast cancer. METHODS:Data of 148 consecutive patients treated with lapatinib and capecitabine from M
Externí odkaz:
https://doaj.org/article/4042b5acfdbe4a8995478f850a8f5aab
Autor:
M. Turazza, Nicla La Verde, Stefania Gori, Filippo Alongi, Matteo Valerio, Antonio Frassoldati, Antonio Russo, Lucio Laudadio, Ornella Garrone, Alessandro Inno, Luigi Cavanna, Alessandra Fabi, Vita Leonardi, Emiliana Tarenzi, Jennifer Foglietta, Gianluigi Lunardi, Elisabetta Cretella, Patrizia Vici, F. Marchetti, Daniele Galanti, S. Moroso, Sandro Barni, Fabio Puglisi
Publikováno v:
Clinical Breast Cancer. 19:e501-e510
There is no sufficient evidence to establish a standard of care for patients with brain metastases (BM) from HER2Data of 154 patients were retrospectively collected at 14 Italian institutions through a specifically designed database.Median overall su
Autor:
Katia Cagossi, A. Ferzi, Domenico Amoroso, A. Baldelli, Luca Clivio, Mariangela Ciccarese, Viola Cogliati, Ornella Garrone, P. Spadaro, Daniele Santini, Vita Leonardi, Elisabetta Cretella, Luca Gianni, A. Gambaro, Alfredo Butera, A. Turletti, M.G. Sarobba, Giovanni Scognamiglio, Vittorio Gebbia, Cristiana Taverniti, F. Ferraù, D. Toniolo, Saverio Cinieri, C. Putzu, S. Capici, Antonino Musolino, Daniele Generali, Paolo Tralongo, Marina Elena Cazzaniga, Valter Torri, Antonino Grassadonia, Andrea Fontana, Emilia Montagna, E. de Conciliis, P. Di Mauro, Maria Rosaria Valerio, Rossana Berardi, Silvana Saracchini, Ferdinando Riccardi, Antonio Febbraro, I. Vallini, Patrizia Vici, Luigi Cavanna, M. G. Schintu, Roberto Valenza, F. Giovanardi, M. Nicolini, Samanta Sarti, Paolo Marchetti
Publikováno v:
Breast Cancer Research and Treatment
Purpose Triple-negative breast cancer (TNBC) represents a subtype of breast cancer which lacks the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2): TNBC accounts for approximately
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c2e402af1fa77d9baa2179b7895123
https://hdl.handle.net/10281/401018
https://hdl.handle.net/10281/401018
Autor:
Nicla La Verde, A.M. D'Ottavio, Francesco Cognetti, Gianfranco Filippelli, Giusy Scandurra, Cecilia Nisticò, Simonetta Stani, Ida Paris, Daniele Alesini, Grazia Arpino, Marianna Giampaglia, Daniele Santini, Alberto Zambelli, Roberta Caputo, Luca Moscetti, Giovanna Catania, Diana Giannarelli, Michele Caruso, Rosalba Rossello, Paola Malaguti, Katia Cannita, Alessandra Fabi, Vita Leonardi, Filippo Montemurro, Michelangelo Russillo, E. Valle, Mariangela Ciccarese, Gianluigi Ferretti, A. Fabbri, Luisa Carbognin
Publikováno v:
The Breast. 41:137-143
Background We reported the results of an Italian large retrospective analysis that evaluated the effectiveness and safety of T-DM1 in ‘field-practice’ breast cancer patients. We performed a sub-analysis to investigate the clinical activity of T-D
Autor:
Daniele Santini, Simonetta Stani, Alberto Zambelli, Alessandra Fabi, Vita Leonardi, Michelangelo Russillo, Daniele Alesini, Daniela Cianniello, Grazia Arpino, Luisa Carbognin, Diana Giannarelli, Michele Caruso, Marianna Giampaglia, Mariangela Ciccarese, Giuseppa Scandurra, Daniele Generali, Rosalba Rossello, E. Valle, A. Fabbri, Gianfranco Filippelli, Filippo Montemurro, Ida Paris, Katia Cannita, Luca Moscetti, Nicla La Verde, A.M. D'Ottavio, Michelino De Laurentiis, Francesco Cognetti
Publikováno v:
Oncotarget
Ado-trastuzumab emtansine (T-DM1) is an antibody-drug conjugate approved for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive, metastatic breast cancer (mBC). The aim of this ‘field-practice’ study was to in
Autor:
Ida Paris, Grazia Arpino, Simonetta Stani, G. Scandurra, N. La Verde, Mariangela Ciccarese, Luisa Carbognin, A.M. D'Ottavio, Daniele Santini, M. De Laurentiis, A. Fabi, E. Valle, Marianna Giampaglia, Rosalba Rossello, Michelangelo Russillo, Daniele Alesini, Katia Cannita, Vita Leonardi, Daniele Generali, Diana Giannarelli, Michele Caruso, Gianfranco Filippelli, Filippo Montemurro, Francesco Cognetti, Alberto Zambelli, Luca Moscetti, A. Fabbri
Publikováno v:
Cancer Research. 77:P4-21
Background: T-DM1 showed remarkable activity in metastatic HER-2 positive breast cancer (mBC) and it was recently approved for clinical use in patients (pts) who previously failed Trastuzumab- and Taxanes-based therapies. Currently, little is known o
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sabino De Placido, Ciro Gallo, Michelino De Laurentiis, Giancarlo Bisagni, Grazia Arpino, Maria Giuseppa Sarobba, Ferdinando Riccardi, Antonio Russo, Lucia Del Mastro, Alessio Aligi Cogoni, Francesco Cognetti, Stefania Gori, Jennifer Foglietta, Antonio Frassoldati, Domenico Amoroso, Lucio Laudadio, Luca Moscetti, Filippo Montemurro, Claudio Verusio, Antonio Bernardo, Vito Lorusso, Adriano Gravina, Gabriella Moretti, Rossella Lauria, Antonella Lai, Carmela Mocerino, Sergio Rizzo, Francesco Nuzzo, Paolo Carlini, Francesco Perrone, Antonello Accurso, Biagio Agostara, Michele Aieta, Oscar Alabiso, Maria Grazia Alicicco, Dino Amadori, Laura Amaducci, Gianna Amiconi, Giustino Antuzzi, Mara Ardine, Antonio Ardizzoia, Caterina Aversa, Giuseppe Badalamenti, Sandro Barni, Carlo Basurto, Rossana Berardi, Cinzia Bergamasco, Paolo Bidoli, Claudia Bighin, Edoardo Biondi, Corrado Boni, Karen Borgonovo, Mario Botta, Stefano Bravi, Paolo Bruzzi, Giuseppe Buono, Alfredo Butera, Alessia Caldara, Giampiero Candeloro, Claudia Cappelletti, Cinzia Cardalesi, Elisabetta Carfora, Anna Cariello, Francesco Carrozza, Giacomo Cartenì, Michele Caruso, Virginia Casadei, Claudia Casanova, Luigi Castori, Luigi Cavanna, Giovanna Cavazzini, Marina Cazzaniga, Mario Chilelli, Paolo Chiodini, Silvia Chiorrini, Fortunato Ciardiello, Mariangela Ciccarese, Saverio Cinieri, Mario Clerico, Mariarosa Coccaro, Mario Comande, Claudia Corbo, Giuseppina Cortino, Stefania Cusenza, Gennaro Daniele, Alfonso Maria D'arco, Giuliana D'auria, Claudio Dazzi, Carmine De Angelis, Filippo de Braud, Gianfranco De Feo, Andrea De Matteis, Michele De Tursi, Anna Di Blasio, Giuseppe di Lucca, Liberato Di Lullo, Francesca Di Rella, Gianfranco Di Renzo, Pia Di Stefano, Aida Di Stefano, Anna Diana, Sara Donati, Agnese Fabbri, Alessandra Fabi, Marina Faedi, Gabriella Farina, Antonio Farris, Antonio Febbraro, Palma Fedele, Piera Federico, Francesco Ferraù, Gianluigi Ferretti, Antonella Ferro, Irene Floriani, Rosachiara Forcignanò, Samantha Forciniti, Valeria Forestieri, Gianni Fornari, Michela Frisinghelli, Vittorio Fusco, Giulia Gallizzi, Antonio Galvano, Antonio Gambardella, Angelo Gambi, Vittorio Gebbia, Erika Gervasi, Mara Ghilardi, Alice Giacobino, Giovanni Giardina, Francesco Giotta, Sara Giraudi, Mario Giuliano, Antonino Grassadonia, Donatella Grasso, Federica Grosso, Lorenzo Guizzaro, Pasquale Incoronato, Lorena Incorvaia, Giovanni Iodice, Nicla La Verde, Vincenzo Labonia, Gabriella Landi, Agnese Latorre, Vita Leonardi, Alessia Levaggi, Gennaro Limite, Linda Lina Bascialla, Lorenzo Livi, Evaristo Maiello, Daniela Mandelli, Ilaria Marcon, Daniela Menon, Michele Montedoro, Lucia Moraca, Anna Moretti, Maria Grazia Morritti, Patrizia Morselli, Antonella Mura, Silvia Mura, Michela Musacchio, Alberto Muzio, Donato Natale, Clara Natoli, Cinzia Nigro, Cecilia Nisticò, Antonio Nuzzo, Michele Orditura, Laura Orlando, Carmen Pacilio, Giuliano Palumbo, Raffaella Palumbo, Felice Pasini, Emanuela Paterno, Antonio Pazzola, Silvia Pelliccioni, Matilde Pensabene, Davide Perroni, Angela Pesenti Gritti, Fausto Petrelli, Maria Carmela Piccirillo, Graziella Pinotti, Claudia Pogliani, Davide Poli, Sonia Prader, Francesco Recchia, Daniele Rizzi, Carmen Romano, Rosalba Rossello, Chiara Rossini, Giuseppina Salvucci, Valeria Sanna, Alessandra Santini, Silvana Saracchini, Clementina Savastano, Giovanni Scambia, Francesco Schettini, Paola Schiavone, Alessio Schirone, Elena Seles, Simona Signoriello, Giuseppe Signoriello, Rosa Rita Silva, Antonia Silvestri, Vittorio Simeon, Ilaria Spagnoletti, Stefano Tamberi, Cristina Teragni, Verena Thalmann, Renato Thomas, Guglielmo Thomas, Amelia Tienghi, Nicola Tinari, Vincenza Tinessa, Federica Tomei, Giuseppe Tonini, Valter Torri, Divina Traficante, Marianna Tudini, Monica Turazza, Roberto Vignoli, Maria Giuseppa Vitale, Alessandra Zacchia, Pasquale Zagarese, Alda Zanni, Laura Zavallone, Maria Zavettieri, Alessandra Zoboli
Background: Uncertainty exists about the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors and, to our knowledge, no trial has directly compared the three aromatase inhibitors anastrozole, exemestane, and letrozole. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::228f7b26d0aa24e9e132d199a80b8f12
http://hdl.handle.net/11573/1309634
http://hdl.handle.net/11573/1309634